Ovarian cancer

You have access
Up-regulation of HDAC6 Results in Poor Prognosis and Chemoresistance in Patients With Advanced Ovarian High-grade Serous Carcinoma
MITSUTAKE YANO, MARIKO MIYAZAWA, NAOKI OGANE, AIKO OGASAWARA, KOSEI HASEGAWA, HISASHI NARAHARA and MASANORI YASUDA

Anticancer Research March 2021, 41 (3) 1647-1654; DOI: https://doi.org/10.21873/anticanres.14927
You have access
YYB-101, a Humanized Antihepatocyte Growth Factor Monoclonal Antibody, Inhibits Ovarian Cancer Cell Motility and Proliferation
HYUN JUNG KIM and KYUN HEO

Anticancer Research February 2021, 41 (2) 671-678; DOI: https://doi.org/10.21873/anticanres.14818
You have access
Relevance of Laparoscopic Surgery for Ovarian Cancer in Well-selected Patients: A Propensity-matched Comparison With Laparotomy
FLORIANE JOCHUM, GABRIELLE AUBRY, MADELEINE PELLERIN, CAMILLE BILLARD, EMILIE FALLER, THOMAS BOISRAME, LISE LECOINTRE and CHERIF AKLADIOS

Anticancer Research February 2021, 41 (2) 955-965; DOI: https://doi.org/10.21873/anticanres.14849
You have access
The Prognostic Relevance of Computed Tomography-assessed Skeletal Muscle Index and Skeletal Muscle Radiation Attenuation in Patients With Gynecological Cancer
ANGIOLO GADDUCCI and STEFANIA COSIO

Anticancer Research January 2021, 41 (1) 9-20; DOI: https://doi.org/10.21873/anticanres.14747
You have access
Hyperthermia During Intraperitoneal Chemotherapy With Paclitaxel or Docetaxel for Ovarian Cancer: Is There Any Benefit?
EELCO DE BREE, DESPOINA KATSOUGKRI, HARA POLIOUDAKI, ELENA TSANGARIDOU, DIMOSTHENIS MICHELAKIS, ODYSSEAS ZORAS and PANAYIOTIS THEODOROPOULOS

Anticancer Research December 2020, 40 (12) 6769-6780; DOI: https://doi.org/10.21873/anticanres.14700
You have access
Microvessels in Epithelial Ovarian Tumors: High Microvessel Density Is a Significant Feature of Malignant Ovarian Tumors
MINNA SOPO, MAARIT ANTTILA, OONA-TUULI MUUKKONEN, SEPPO YLÄ-HERTTUALA, VELI-MATTI KOSMA, LEEA KESKI-NISULA and HANNA SALLINEN

Anticancer Research December 2020, 40 (12) 6923-6931; DOI: https://doi.org/10.21873/anticanres.14716
You have access
Survival After Primary Surgery Compared With Neoadjuvant Chemotherapy in Early-stage Ovarian Cancer
DEANNA HUFFMAN, RODNEY WEGNER, AMJAD JALIL, THOMAS KRIVAK and EIRWEN MILLER

Anticancer Research November 2020, 40 (11) 6003-6008; DOI: https://doi.org/10.21873/anticanres.14621
You have access
WNT Signaling Driven by R-spondin 1 and LGR6 in High-grade Serous Ovarian Cancer
SANGHOON LEE, JOHN JUN, WILLIAM J. KIM, PABLO TAMAYO and STEPHEN B. HOWELL

Anticancer Research November 2020, 40 (11) 6017-6028; DOI: https://doi.org/10.21873/anticanres.14623
You have access
Azidothymidine (AZT) Inhibits Proliferation of Human Ovarian Cancer Cells by Regulating Cell Cycle Progression
YEUNTING HSIEH and JENN-JHY TSENG

Anticancer Research October 2020, 40 (10) 5517-5527; DOI: https://doi.org/10.21873/anticanres.14564
You have access
Successful Management of Platinum-resistant Ovarian Cancer by Weekly Nedaplatin Followed by Olaparib: Three Case Reports
SHU SOEDA, TAKAFUMI WATANABE, NORIHITO KAMO, TETSU SATO, CHIKAKO OKABE, MAKIKO UEDA, YUTA ENDO, KOJIMA MANABU, SHINJI NOMURA, SHIGENORI FURUKAWA, HIDEKAZU NISHIGORI, TOSHIFUMI TAKAHASHI and KEIYA FUJIMORI

Anticancer Research September 2020, 40 (9) 5263-5270; DOI: https://doi.org/10.21873/anticanres.14530

Main menu

User menu

Search

Ovarian cancer

Pages